Korro Bio (KRRO) SVP Dolan sells 3,383 shares to cover RSU taxes
Rhea-AI Filing Summary
Korro Bio, Inc. Senior Vice President of Finance Oliver Dolan reported an open-market sale of 3,383 shares of common stock on June 16, 2026 at a weighted-average price of $10.83 per share. According to the footnotes, this was a mandatory sale solely to cover tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs) granted under the company’s 2023 Stock Option and Incentive Plan.
After this transaction, Dolan holds 18,099 shares of common stock directly, which includes 10,741 shares issuable upon settlement of an RSU that is scheduled to vest on December 15, 2026, provided he maintains a continuous service relationship through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,383 shares
Net Sell
1 txn
Insider
Dolan Oliver
Role
Senior Vice President, Finance
Sold
3,383 shs ($37K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,383 | $10.83 | $37K |
Holdings After Transaction:
Common Stock — 18,099 shares (Direct)
Footnotes (3)
- F1. Represents the mandatory sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting and settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan).
- F2. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $10.58 to $11.35, inclusive. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
- F3. Includes 10,741 shares of common stock issuable upon settlement of a RSU granted under the 2023 Plan that will vest on December 15, 2026 subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through such date.
Key Figures
Shares sold: 3,383 shares
Weighted-average sale price: $10.83/share
Post-transaction holdings: 18,099 shares
+2 more
5 metrics
Shares sold
3,383 shares
Open-market sale on June 16, 2026
Weighted-average sale price
$10.83/share
Common stock sale on June 16, 2026
Post-transaction holdings
18,099 shares
Common stock held directly after transaction
Unvested RSU shares
10,741 shares
RSU under 2023 Plan vesting December 15, 2026
Sale price range
$10.58–$11.35/share
Multiple transactions underlying the weighted-average price
Key Terms
restricted stock unit (RSU), weighted-average price, 2023 Stock Option and Incentive Plan, tax withholding obligations
4 terms
restricted stock unit (RSU) financial
"upon vesting and settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
2023 Stock Option and Incentive Plan financial
"granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan)."
tax withholding obligations financial
"mandatory sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting"
FAQ
What insider transaction did Korro Bio (KRRO) report for Oliver Dolan?
Korro Bio reported that Senior Vice President of Finance Oliver Dolan sold 3,383 shares of common stock at a weighted-average price of $10.83. The sale was mandatory to satisfy tax withholding obligations from vested restricted stock units under the company’s 2023 stock plan.
Was the KRRO insider sale by Oliver Dolan a discretionary trade?
The sale was described as mandatory and executed solely to cover tax withholding obligations from vesting and settlement of RSUs. This indicates a tax-related transaction under the 2023 Stock Option and Incentive Plan, rather than a discretionary open-market sale driven by personal investment decisions.
What are Oliver Dolan’s holdings in Korro Bio (KRRO) after this Form 4 transaction?
After the reported transaction, Oliver Dolan holds 18,099 shares of Korro Bio common stock directly. This figure includes 10,741 shares issuable upon settlement of an RSU grant scheduled to vest on December 15, 2026, contingent on his continued service relationship with the company.
What RSU award terms were disclosed for Korro Bio (KRRO) executive Oliver Dolan?
The filing notes an RSU award covering 10,741 shares of Korro Bio common stock under the 2023 Stock Option and Incentive Plan. These RSUs are expected to vest on December 15, 2026, provided Oliver Dolan maintains a continuous service relationship with Korro Bio through that date.
How was the sale price range described in the Korro Bio (KRRO) Form 4 filing?
The weighted-average sale price reported was $10.83 per share. Footnotes clarify the shares were sold in multiple transactions at prices ranging from $10.58 to $11.35, and more detailed trade information can be obtained from Korro Bio, any security holder, or SEC staff upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
